基本信息：
贾永亮，男，博士，硕士生导师
地址：郑州市大学路40号
邮箱：jiayl@zzu.edu.cn, gentrany@gmail.com
电话：0371-61730291
邮编：450052
学习经历：
2021.4 - 至今 郑州大学河南省医药科学研究院代谢精准医学中心 讲师
2013.08 - 2020.12 澳门大学 哲学（生物医药） 博士
2009.08 - 2012.02 澳门大学 理学（医药管理） 硕士
2005.08 - 2009.06 兰州大学 医学（药学） 学士
2005.08 - 2009.06 兰州大学 理学（电子信息科学与技术） (双)学士
研究方向和兴趣：
(1) 循证医学方面证据质量评价和疗效综合比较；
(2) 生物信息学和临床试验的数据挖掘和分析；
(3) 证据理论和论证理论在医学决策中的应用；
(4) 生物信息学多源证据的合并分析疾病的潜在病因；
(5) 大量数据和统计分析下计算自动化和智能化的考量。
学术兼职：
BioMed Research International, 学术编辑 (Academic Editor)
《河南医学研究》杂志，青年审稿专家
中国医药教育协会医学基因组学与生物信息学专业委员会，青年委员
Alzheimer's Research & Therapy; Diabetes, Obesity and Metabolism; Phytomedicine等数十种SCI期刊审稿人
科研项目：
l 2023/1 – 2023/12
主持, 河南省医药科学研究院科研项目“抗抑郁疗法的证据评价” (2023BP0104)
l 2022/1 – 2023/12
主持, 河南省重点研发与推广专项(科技攻关)项目“全球COVID-19临床试验的批判性研究” (222102310721)
l 2021/8 – 2024/8
主持, 郑州大学科研项目“心绞痛药物治疗临床证据的全面分析” (32212456)
l 2021/6 – 2022/12
主持, 河南省医药科学研究院科研项目“抗抑郁常用疗法的网络荟萃分析” (2021BP0113)
l Jun. 2013 – Mar. 2018
Principal Investigator, “Genomic meta-analysis by social computation in biomedical informatics” from the
University of Macau (MYRG2014-00117-ICMS-QRCM, Program Director - Leung Siu-wai)
l Jun. 2013 – Dec. 2013
Principal Investigator, “Open systematic reviewing of clinical trials” from the University of Macau
(MYRG190-Y3-L3-ICMS-LSW, Program Director - Leung Siu-wai)
l Dec. 2011 – Jun. 2013
Principal Investigator, “Open systematic reviewing of clinical trials” from the University of Macau
(MYRG190 (Y1-L3)-ICMS11-LSW, Program Director - Leung Siu-wai)
l Jul. 2010 – Jun. 2011
Principal Investigator, “An Empirical Analysis of China Health Care Industry” from the University of Macau (SRF021/09-10S/JY/FBA, Program Director - Yuan Jia)
发表论文：
†共同一作，*通讯作者
1. Yongliang Jia†, Yaoguang Lao†, Hongmei Zhu, Ning Li, Siu-wai Leung*. Is metformin still the most efficacious first-line oral hypoglycemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials. Obesity Reviews 2019; 20(1):1-12.
2. Yongliang Jia†*, Guoying Gao†, Siu-wai Leung. How efficacious are traditional Chinese medicine injections in treating angina pectoris? A network meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 2023; 303:115996.
3. Tong Wu, Tieliang Yue, Pengfei Yang, Yongliang Jia*. Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials. Journal of Ethnopharmacology 2022; 294;115367.
4. Miao Jiang†, Yongliang Jia†, Jinming Han, Jianxiang Shi, Chang Su, Rui Zhang, Menglu Xing, Shuiling Jin*, HongZong*. Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data. Frontiers in Genetics 2022; 13:963964. DOI: 10.3389/fgene.2022.963964.
5. Guoying Gao, Siu-wai Leung, Yongliang Jia*. Serious Concerns About the RCT Study Quality of Traditional Chinese Medicine Injections for Treating Cardiovascular Diseases and COVID-19. Cardiovascular Drugs and Therapy 2021; 35(1): 191-193.
6. Yongliang Jia, Siu-wai Leung. Efficacy of Chinese herbal drugs for angina pectoris: frequentist network meta-analyses. The Lancet 2017; 390: S72.
7. Yongliang Jia, Fangyi Huang, Shikai Zhang, Siu-wai Leung*. Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. International Journal of Cardiology 2012; 157(3):330-40.
8. Yongliang Jia, Hongmei Zhu, Siu-wai Leung*. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomized controlled trials. BMJ Open 2016; 6(6):e010142.
9. Yongliang Jia, Yaoguang Lao, Siu-wai Leung*. Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis. BMJ Open 2015; 5(3):e006139.
10. Yongliang Jia, Siu-wai Leung*. Drug efficacy in treating stable angina pectoris: a protocol for network meta-analysis of randomised controlled trials. BMJ Open 2014; 4(6):e005453.
11. Yongliang Jia, Leung Siu-wai*. How efficacious is danshen (Salvia miltiorrhiza) dripping pill in treating angina pectoris? Evidence assessment for meta-analysis of randomized controlled trials. Journal of Alternative and Complementary Medicine 2017; 23(9):676-684.
12. Yongliang Jia, Leung Siu-wai*. Comparative efficacy of tongxinluo capsule and beta-blockers in treating angina pectoris: meta-analysis of randomized controlled trials. Journal of Alternative and Complementary Medicine 2015; 21(11):686-99.
13. Yongliang Jia, Siu-wai Leung*, Ming-Yuen Lee*, Guozhen Cui, Xiaohui Huang, Fongha Pan. The efficacy of Guanxinning Injection in treating angina pectoris: systematic review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2013; 282707.
14. Yongliang Jia, Shikai Zhang, Fangyi Huang, Siu-wai Leung*. Could ginseng-based medicines be better than nitrates in treating ischemic heart disease? A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 2012; 20(3):155-66.
15. Yongliang Jia, Cong Chen, Choi-San Ng, Siu-wai Leung*. Meta-analysis of randomized controlled trials on the efficacy of di’ao xinxuekang capsule and isosorbide dinitrate in treating angina pectoris. Evidence-Based Complementary and Alternative Medicine 2012; 904147.
16. Yongliang Jia, Feifei Bao, Fangyi Huang, Siu-wai Leung*. Is tongxinluo more effective than isosorbide dinitrate in treating angina pectoris? A systematic review and meta-analysis of randomized controlled trials. Journal of Alternative and Complementary Medicine 2011; 17(12):1109-17.
17. Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung*. Prediction of Differentially Expressed MicroRNAs in Blood as Potential Biomarkers for Alzheimer’s Disease by Meta-Analysis and Adaptive Boosting Ensemble Learning. Alzheimer's Research & Therapy 2021; 13 (1):1-30.
18. Puipui Tang, Ilam Tam, Yongliang Jia, Siu-wai Leung*. Big Data Reality Check (BDRC) for Public Health: How much environmental health and health services research did meet the “V” criteria for big data? A study protocol. BMJ Open 2022; 12(3): e053447.
19. Jinming Han, Jianxiang Shi, Miao Jiang, Ruowen Zhang, Shuiling Jin*, Yongliang Jia*, Hong Zong*. Clinical Characteristics and Prognostic Values of PIK3CA Mutation in Colorectal Cancer Patients. Journal of Cancer Science and Clinical Therapeutics 2022; 6: 121-132.
20. 中国耳聋基因筛查与诊断临床多中心研究协作组 (包括贾永亮). 中国耳聋基因诊断与遗传咨询临床实践指南(2023). 中华耳鼻咽喉头颈外科杂志 2023; 58 (1):3-14.
21. 贾永亮, 张时开, 鲍菲飞, 黄芳艺, 梁少伟*. 通心络胶囊与丹参滴丸治疗冠心病心绞痛间接比较的系统评价. 中国循证医学杂志2011; 11 (8):919-931.
22. 贾永亮, 黄芳艺, 张时开, 梁少伟*. 中成药治疗冠心病随机对照试验方法学质量评价. 中国中西医结合杂志 2012; 32 (4):631-640.
23. 贾永亮, 贾伟芳, 陈聪, 阮贞. 血栓心脉宁治疗脑梗死临床随机对照试验的系统评价. 中国实用神经疾病杂志 2012; 15 (22), 78-80.
24. 闫勇闯, 王志刚, 齐元博, 丰翼, 丰永花, 贾永亮, 成富民, 丰贵文, 姜伟, 尚文俊*. 学龄后儿童肾移植后BK多瘤病毒感染的影响因素及其预测模型构建. 中华医学杂志 2023; 103(20):1538-1545.
25. 吴翠珊, 王善萍, 张君隆, 吴玉丹, 贾永亮, 梁少伟*. 比较复方丹参滴丸与地奥心血康胶囊治疗心绞痛随机对照临床试验的系统评价和 meta 分析. 中国中西医结合学报 2012; 10(1): 25-34.
26. 马子娇, 许颖, 刘佳, 赵永雪, 贾永亮, 倪京满. 甘草废渣中甘草黄酮提取工艺研究. 中国实验方剂学杂志2010; 16 (15):15-19.
会议论文：
1. Yongliang Jia, Siu-wai Leung. Efficacy of Chinese herbal drugs for angina pectoris: frequentist network meta-analyses. The Lancet-CAMS Health Summit 2017. Beijing, China. (Poster).
2. Yongliang Jia. A frequentist network meta-analysis of randomized controlled trials with traditional Chinese medicine injections for angina pectoris. 中华医学会第二十一届全国临床流行病学和循证医学学术会议 2023. 兰州, 中国. (Oral presentation).
3. Yongliang Jia, Hui Zhou, Hongmei Zhu. Evidence assessment of randomized controlled trials with traditional Chinese medicines against the coronavirus disease 2019. 中华医学会第二十一届全国临床流行病学和循证医学学术会议 2023. 兰州, 中国. (Poster).
4. Yongliang Jia, Pengfei Yang. Efficacy of Shugan Jieyu capsule for adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials. 中华医学会第二十届全国临床流行病学和循证医学学术会议 2022. 上海, 中国. (Poster).
5. Yongliang Jia*. The critical appraisal of meta-analysis of Kidney transplantation with the PRISMA checklist and the GRADE approach. 第十五届中国卫生技术评估论坛 2022. 上海, 中国. (Poster).
6. Yongliang Jia, Siu-wai Leung*. Efficacy of Chinese herbal drugs versus chemical drugs in treating stable angina pectoris: a Bayesian network meta-analysis of randomized controlled trials. 中华医学会第十九届全国临床流行病学和循证医学学术会议2021. 郑州, 中国. (Oral presentation).
7. Heng Yin, Yinuo Cheng, Yongliang Jia*. Efficacy of Mahuang Lianqiao Chixiaodou decoction in treating adults with acute glomerulonephritis: A meta-analysis of randomized clinical trials. 中华医学会第十九届全国临床流行病学和循证医学学术会议 2021. 郑州, 中国. (Poster).
8. 岳铁梁，毋桐，杨鹏飞，贾永亮*. 疏肝解郁胶囊治疗卒中后抑郁随机对照试验的系统评价和meta分析. 中华医学会第十九届全国临床流行病学和循证医学学术会议 2021. 郑州, 中国. (海报).
9. Hongmei Zhu, Yongliang Jia, Siu-wai Leung*. Blind citations of retractions. The 7th World Conference on Research Integrity 2022; Cape Town, South Africa. (Oral presentation).
10. Yongliang Jia, Siu-wai Leung*. The assessment of evidence assessment from meta-analysis on Chinese herbal drugs. The 15th Meeting of Consortium for Globalization of Chinese Medicine (CGCM) 2016. Taipei, China. (Poster).
11. Yongliang Jia, Ning Li, Siu-wai Leung*. Efficacy of thiazolidinediones in treating type 2 diabetes: Bayesian and Frequentist multi-level meta-analyses of randomized control trials. The 9th Asia-Pacific Conference on Evidence-Based Medicine 2016. Chengdu, China. (Oral presentation).
12. Yongliang Jia, Siu-wai Leung*. Comparative efficacies of Chinese herbal medicine and nitrates in treating stable angina pectoris: network meta-analysis of randomized controlled trials. 2nd International Conference of Traditional and Complementary Medicine on Health 2015. Taipei, Taiwan, China. (Poster).
13. Yongliang Jia, Siu-wai Leung*. Comparative efficacy of chemical drugs and Chinese herbal drugs in treating stable angina pectoris: a network meta-analysis of randomized controlled trials. The 8th Asia-Pacific Conference on Evidence-Based Medicine 2015. Chongqing, China. (Oral presentation).
14. Yongliang Jia, Siu-wai Leung*. Comparative efficacy of tongxinluo capsule and beta-blockers in treating angina pectoris: meta-analysis of randomized controlled trials. The 13th Meeting of CGCM 2014. Beijing, China. (Oral presentation).
15. Yongliang Jia, Siu-wai Leung*. Indirect meta-analysis of Baoxin pill, Tongxinluo capsule, and isosorbide dinitrate for angina pectoris. The 11th Meeting of CGCM 2012. Macau SAR, China. (Poster).
16. Yongliang Jia, Siu-wai Leung*. Large-scale network meta-analysis of major Chinese medicines for treating ischemic heart disease. The 10th Meeting of Consortium for Globalization of Chinese Medicine 2011. Shanghai, China. (Poster).
17. Yongliang Jia, Siu-wai Leung*. Quality assessment of RCTs on Danshen Dripping Pills (DSP) in treating angina pectoris. The 9th Meeting of CGCM 2010. Hong Kong SAR, China. (Poster).
18. Guoying Gao, Yongliang Jia, Siu-wai Leung*. Is Dengzhanxixin injection more effective than nitrates in treating angina pectoris? A meta-analysis of randomized controlled trials. The 16th Meeting of CGCM 2017. Guangzhou, China. (Oral presentation).
19. Ning Li, Yaoguang Lao, Yongliang Jia, Siu-wai Leung*. A multilevel model framework for network meta-analysis. International Conference on Evaluation of Post-marketing of Chinese Medicine 2013. Beijing, China. (Oral presentation).
